Clinical and Genetic Studies in Familial Non-Medullary Thyroid Cancer

  • participants needed
  • sponsor
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Updated on 21 October 2022


  • Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of thyroid cancer, but little is known about possible genes that may cause the cancer. More research is needed to develop the best ways to screen for familial non-medullary thyroid cancer (FNMTC) so that it can be diagnosed and treated at an early stage.
  • To evaluate the natural history of FNMTC.
  • To determine the best screening strategy for FNMTC.
  • To identify genes that may indicate susceptibility to FNMTC.
  • Individuals at least 7 years of age who have two first-degree relatives (e.g., parents, children, siblings) who have or have had non-medullary thyroid cancer or a documented diagnosis of non-medullary thyroid cancer and one living relative with documented non-medullary thyroid cancer.
  • Participants will be evaluated by family history pedigree, physical examination, imaging (including possible neck ultrasound and radioactive iodine scans), and laboratory testing.
  • Participants who agree to have blood or other biological samples collected will be asked to enroll in an additional study to provide the appropriate samples and tissues.
  • After the initial study evaluation, participants who are not found to have a malignant thyroid tumor will be re-screened every year with non-invasive imaging studies. Participants who are found to have a malignant thyroid tumor will be informed of possible treatment options.


Study Description:

This is a prospective cohort study of individuals with or at risk for non-medullary thyroid cancer. Individuals will be studied over time within the context of their families in order to quantify prospective risks of cancers in family members, to establish the natural history of FNMTC, define the spectrum of diseases within the families, to identify precursor states, to try to assess the contribution of genetic and environmental components of risk, and to develop effective screening strategies.

  1. To evaluate the natural history of familial non-medullary thyroid cancer (FNMTC).
  2. To determine the best screening strategy for FNMTC.
  3. To identify susceptibility gene(s) for FNMTC.

Not applicable

Condition Non-Medullary Thyroid Cancer
Clinical Study IdentifierNCT01109420
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last Modified on21 October 2022


Yes No Not Sure

Inclusion Criteria

Subjects will be selected for this protocol based on either a clinical diagnosis of
non-medullary thyroid cancer and the presence of one family member with the disease or the
presence of 2 living family members with this disease. Patient selection for this protocol
will not be based on gender, race, or ethnic background
In order to be eligible to participate in this study, an individual must meet all of the
following criteria
Adults or minor (>= 7 years+), males and females
An unaffected individual with (Bullet) 2 first-degree relatives who have or have had
nonmedullary thyroid cancer
Adults must be able to complete the family history questionnaire
An affected individual with documented diagnosis of non-medullary thyroid cancer and
(Bullet) one living relative with documented non-medullary thyroid cancer (Note: as this is
a familial study, subjects do not need to present with the disease)
Any member of an affected family. (Note: for this study, an affected family is defined
as a family having 2 or more 1st degree relatives with a documented diagnosis of
Adults must be able to understand and the willingness to sign the informed consent

Exclusion Criteria

An individual who meets any of the following criteria will be not be allowed to enroll in
this study
Subjects unwilling/unable to give informed consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note